Stock Screener App

Frei -

Installieren

2.47

0.80% -0.02

Biomerica Inc (BMRA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BMRA? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$2.49

Offen:

$2.45

24-Stunden-Volumen:

17,376

Relative Volume:

0.80

Marktkapitalisierung:

$7.63M

Einnahmen:

$4.33M

Nettoeinkommen (Verlust:

$-4.17M

KGV:

-1.6518

EPS:

-1.4953

Netto-Cashflow:

$-3.19M

1W Leistung:

+3.78%

1M Leistung:

+15.42%

6M Leistung:

+6.47%

1J Leistung:

-20.58%

1-Tages-Spanne:

$2.39

$2.47

1-Wochen-Bereich:

$2.20

$2.49

52-Wochen-Spanne:

$1.8664

$4.60

Biomerica Inc Stock (BMRA) Company Profile

Firmenname

Biomerica Inc

Sektor

Healthcare (1110)

Branche

Medical Devices (143)

Telefon

(949) 379-2875

Adresse

17571 VON KARMAN AVENUE, IRVINE, CA

Mitarbeiter

54

Twitter

@biomerica_inc

Nächster Verdiensttermin

2026-04-13

Neueste SEC-Einreichungen

BMRA's Discussions on Twitter

Compare BMRA vs ABT, SYK, MDT, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BMRA Biomerica Inc	2.47	7.69M	4.33M	-4.17M	-3.19M	-1.4953
ABT Abbott Laboratories	86.70	152.25B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	312.36	121.33B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	77.84	100.91B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	57.84	85.88B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	87.78	49.39B	6.30B	1.07B	1.09B	1.8406

Biomerica Inc Stock (BMRA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2020-11-10	Eingeleitet	Colliers Securities	Buy
2018-01-04	Eingeleitet	B. Riley FBR, Inc.	Buy

Biomerica Inc Aktie (BMRA) Neueste Nachrichten

Biomerica Inc. (BMRA) Q1 2026 Earnings: Negative EPS Persists Amid Pre-Revenue StagePeak Earnings Alert - Newser

BMRA Q1 2026 Earnings: Biomerica Reports Net Loss of $0.44 Per Share Amid Ongoing Development Efforts - Newser

BMRA Stock Price, Quote & Chart | BIOMERICA INC (NASDAQ:BMRA) - ChartMill

Biomerica (BMRA) Q1 2026 Earnings: Revenue $N/A, Matching ViewsExpert Entry Points - Newser

ConsumerDirect names Gary Lu as chief financial officer - Investing.com UK

ConsumerDirect names Gary Lu as chief financial officer By Investing.com - Investing.com South Africa

ConsumerDirect adds new CFO to scale its subscription business - Stock Titan

Biomerica (BMRA) Stock Analysis: Falls -3.85%, Watching $2.14 2026-05-18Most Watched Stocks - newser.com

Should You Sell Biomerica (BMRA) After -2.90% Drop? 2026-05-17Crowd Sentiment Stocks - Newser

TradingKey - TradingKey

What Biomerica (BMRA) subscription metrics reveal about retention | BMRA Q1 2026: Biomerica Posts Wider Loss Amid Cost PressureCrowd Breakout Signals - Newser

BMRA | BIOMERICA INC Insider Trading - Quiver Quantitative

What nobody tells you about Biomerica (BMRA) stock (Smart Money Outflows) 2026-05-08Golden Cross - Newser

Why are smart money investors paying attention to Biomerica (BMRA)? (On the Radar) 2026-05-07Verified Stock Signals - newser.com

How Biomerica (BMRA) competitive position is evolving (Bullish Momentum) 2026-05-06Social Investment Platform - newser.com

Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 - Weekly Voice

An IBS diet-guided therapy gets a slot at the world's biggest GI meeting - Stock Titan

BMRA (Biomerica) falls 0.47% after reporting Q1 2026 negative EPS of $-0.44 with no available analyst consensus estimates.Social Buy Zones - newser.com

BMRA (Biomerica Inc.) posts 1.9 percent year-over-year Q1 2026 revenue dip, shares gain 4.27 percent. - Cổng thông tin điện tử tỉnh Lào Cai

BMRA (Biomerica Inc.) slips 0.91% following Q1 2026 earnings release with no available analyst consensus estimates.Hedge Fund Inspired Picks - Xã Thanh Hà

Biomerica Q3 Sales Fall, Net Loss Widens Amid Restructuring - Orange County Business Journal

BMRA Biomerica reports 1.9% year-over-year Q1 2026 revenue decline, shares drop 2.52% in today’s session.Popular Market Picks - Newser

Biomerica (BMRA) Stock Bid Wall (Near Lows) 2026-04-18Live Trade Sharing - Newser

Biomerica (BMRA) Secures Medicare Coverage for inFoods IBS Tests - GuruFocus

Biomerica, Inc. Receives Medicare Confirmation for inFoods® IBS Claims Processing Pathway - Quiver Quantitative

Biomerica Inc Announces Medicare Administrative Contractor Confirmation of Individual Claim Review For Infoods Ibs Test - marketscreener.com

Biomerica (BMRA) Stock Bonus Issue (Investor Interest) 2026-04-15Trader Community Insights - Cổng thông tin điện tử Tỉnh Sơn La

Biomerica, Inc., Phoenix Airmid Biomedical And CanAlt Health Labs Launch inFoods IBS Platform In Canada - marketscreener.com

Biomerica reports net loss of USD 1.31M in Q3 2026 - Medical Buyer

Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs - The Manila Times

Up to 5 million Canadians have IBS; Biomerica brings inFoods north - Stock Titan

Biomerica's Q3 revenue falls, net loss widens on lower manufacturing sales - TradingView

Biomerica Reports Third Quarter Fiscal 2026 Financial Results - Weekly Voice

Biomerica Reports Third Quarter Fiscal 2026 Financial Results, Highlights Real-World Efficacy of inFoods® IBS and Growth in European Revenue - Quiver Quantitative

BRIEF-Biomerica Q3 Net Income USD -1.31 Million - TradingView

Press Release: Biomerica Reports Third Quarter Fiscal 2026 Financial Results - Moomoo

Biomerica 10-Q: Revenue $0.99M, EPS $(0.44) for Q3 ended Feb 28, 2026 - TradingView

Biomerica (BMRA) revenue falls 22% as losses persist and going concern risk disclosed - Stock Titan

Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 - marketscreener.com

Update Report: Will Biomerica Inc stock benefit from M A2026 Earnings Impact & Weekly Stock Breakout Alerts - baoquankhu1.vn

What metrics matter for Biomerica (BMRA) Stock valuation | Price at $2.05, Down 4.11%Open Trading Community - Newser

Aug Breakouts: Is Biomerica Inc a strong candidate for buy and holdMarket Volume Summary & Risk Controlled Daily Trade Plans - baoquankhu1.vn

Press Releases about Biomerica, Inc.Common Stock (Nasdaq:BMRA) - FinancialContent

How does Biomerica (BMRA) Stock compare to competitors | Price at $2.16, Up 0.47%Take Profit Levels - Newser

Biomerica (BMRA) to Post Earnings on Monday - Defense World

BMRA: BiomericaInteractive Chart - Zacks Investment Research

Is Biomerica (BMRA) Stock Moving Sideways | Price at $2.17, Down 0.91%Trending Buy Opportunities - Xã Vĩnh Công

Should value investors consider Biomerica Inc2026 Price Targets & AI Enhanced Trade Execution Alerts - baoquankhu1.vn

AI Stocks: Whats the fair value of Biomerica Inc stockMarket Risk Report & Fast Gain Swing Alerts - baoquankhu1.vn

Rate Hike: What is the PEG ratio of Biomerica Inc2026 EndofYear Setup & Stock Portfolio Risk Management - baoquankhu1.vn

BMRA PE Ratio & Valuation, Is BMRA Overvalued - intellectia.ai

Finanzdaten der Biomerica Inc-Aktie (BMRA)

Umsatz

Nettogewinn

Free Cashflow

ENV

ZBH

$85.11

0.32%

STE

$215.00

2.22%

PHG

$27.12

0.22%

DXCM

$71.14

0.17%

GEHC

$63.91

0.23%

EW

$86.29

3.64%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters